PHK
RLAY icon

Point72 Hong Kong’s Relay Therapeutics RLAY Stock Holding History

Point72 Hong Kong’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,624
Closed -$81K – 1355
2022
Q3 		$81K Buy
+3,624
New +$79.5K ﹤0.01% 1291
2021
Q4 		– Sell
-11,267
Closed -$355K – 2305
2021
Q3 		$355K Buy
+11,267
New +$379K 0.01% 1022

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Point72 Hong Kong's RLAY Position: Q4 2022 in Review

Point72 Hong Kong sold out of Relay Therapeutics (RLAY) in Q4 2022, closing a stake of 3,624 shares — an estimated $81K sold.

Point72 Hong Kong first reported a position in RLAY in Q3 2021 and held it in 2 quarters. The position peaked at $355K in Q3 2021. 165 funds tracked by Wall St. Rank hold RLAY as of Q4 2022.

  • Point72 Hong Kong reported no remaining Relay Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,624 Relay Therapeutics shares in Q4 2022, an estimated $81K.
  • Point72 Hong Kong first reported a position in Relay Therapeutics in Q3 2021 and held it in 2 quarters.
  • Point72 Hong Kong's Relay Therapeutics position peaked at $355K in Q3 2021.
  • 165 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.